AI expertise meets medical device excellence. A rare combination for a unique challenge.
The device presented is under preclinical/clinical investigation. It is not FDA approved nor CE labelled.
GOVERNANCE
Board of Directors
Strategic oversight and capital allocation.
Sam Errama
CHAIRMAN
Platform architecture and AI strategy. Drives board-level decisions on technology roadmap, regulatory posture, and capital deployment.
Taha Errama
DIRECTOR
Governance and technology oversight across the hardware, optical, and AI stack.
EXECUTIVE TEAM
The team that built the system is the team commercializing it.
Christophe Bailleul
CCRO: CHIEF CLINICAL AND REGULATORY OFFICER
25+ years in atrial fibrillation, with deep expertise in clinical trial design, market access and reimbursement strategy. Led biventricular pacemaker clinical development through CE/PMA and integration into medical guidelines. Previously VP and Director at ELA/Sorin, St. Jude Medical and Mauna Kea Technologies. Co-founder of Co-Decision Technology S.A.S.
Focus:
Clinical trial design and execution
FDA and EU MDR regulatory pathways
Medical device quality management system
Lucia Colmenero
CFO: CHIEF FINANCIAL OFFICER
15+ years in banking, international controllership and financial management of high-growth technology start-ups. Previously Financial Manager for SMEs at "la Caixa" and financial lead at Integromics (acquired by PerkinElmer in 2014). Significant experience with public funding and national and European programmes.
Focus:
Corporate finance and planning
Capital deployment against the Series A plan
Operations and people
David Herranz
PRE-CLINICAL AND CLINICAL DIRECTOR
18+ years in research and medical device development, with 12 years leading preclinical programmes, regulatory documentation and multidisciplinary technical teams, including the execution of several clinical trials. Project leader on three programmes funded by the Spanish Ministry of Science and Innovation through public-private collaborations. Specialist in ablation systems for atrial fibrillation, with end-to-end project execution expertise. Twenty-plus peer-reviewed publications.
Focus:
Preclinical model design and execution
Clinical study operations and site coordination
Translational evidence for the AI Engine
Abel Roige
RND DIRECTOR
Bachelor's in Materials Engineering and PhD in Materials Science and Optical Characterisation. 10+ years leading R&D projects across multidisciplinary teams, advanced technologies and start-up environments, including six years focused on the medical device industry. Extensive experience in product development and V&V activities for medical products, with contributions to multiple preclinical and clinical trials.
Focus:
Optical engineering and PS-OCR signal chain
Console and catheter systems integration
Technical roadmap toward regulatory submission
MEDICAL ADVISORY BOARD
Thirteen advisors across seven countries.
The electrophysiologists and scientists advising the programme include the co-authors and proctors of the AblaView® peer-reviewed publications.
NORTH AMERICA
Prof. Atul Verma, MD
MONTREAL, CANADA
Electrophysiology Unit, Cardiology Department, McGill University Health Centre.
Co-author and proctor, AblaView® first-in-human study (Europace, 2025). 300+ peer-reviewed publications including NEJM. Led STAR AF II.
Dr. Maria Terricabras, MD
TORONTO, CANADA
Electrophysiology Unit, Sunnybrook Medical Center, University of Toronto.
Lead author, AblaView® PS-OCR preclinical study (Circulation, 2024). Specialist in preclinical evaluation of new ablation devices.
EUROPE
Prof. Sabine Ernst
LONDON, UK
Senior Consultant Electrophysiology, Imperial College, Royal Brompton Hospital.
Dr. Tom de Potter
AALST, BELGIUM
Head Electrophysiologist, OLV Hospital Aalst.
Prof. Raphael Martins, MD, PhD
RENNES, FRANCE
Cardiology Department, CHU Rennes / University of Rennes.
Co-author and proctor, AblaView® first-in-human study (Europace, 2025). AF mechanisms and translational ablation research.
Head of Arrhythmia Unit, Cardiology Department, Hospital Universitario La Paz.
Prof. Giorgi Papiashvili
TBILISI, GEORGIA
Head of Arrhythmia Department, Jo Ann University Hospital.
Co-author on the AblaView® publications.
Prof. Lluis Mont
BARCELONA, SPAIN
Head of Arrhythmia Section, Hospital Clinic, Universitat de Barcelona.
WHY THIS TEAM WINS
Both sides of a rare combination.
Most medical device companies lack AI expertise. Most AI companies lack medical device experience. AblaView® has both. We bridge the gap between advanced machine learning and the rigorous safety requirements of the cardiac cath lab.
01
AI/ML Expertise
02
Systems Thinking
03
Execution Focus
04
Strategic Vision
CAREERS
We are hiring in Madrid.
Open roles across hardware, catheter production, and biomedical engineering, plus how the hiring process runs.
